2009
DOI: 10.4161/hv.5.2.6924
|View full text |Cite
|
Sign up to set email alerts
|

Rotavirus vaccines: Opportunities and challenges

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
45
0
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(46 citation statements)
references
References 111 publications
(212 reference statements)
0
45
0
1
Order By: Relevance
“…27 Vomiting is a recognisable barrier to the effective use of ORT, and this is because some caregivers are unaware of the need to continue giving ORT and other feeds to their child after the vomiting has subsided. 33 In some cases, this practice is attributable to the caregivers' level of education, and the quality of diarrhoea-related health messages that they receive. 34,35 Several studies have been conducted on this subject in our context.…”
Section: Introductionmentioning
confidence: 99%
“…27 Vomiting is a recognisable barrier to the effective use of ORT, and this is because some caregivers are unaware of the need to continue giving ORT and other feeds to their child after the vomiting has subsided. 33 In some cases, this practice is attributable to the caregivers' level of education, and the quality of diarrhoea-related health messages that they receive. 34,35 Several studies have been conducted on this subject in our context.…”
Section: Introductionmentioning
confidence: 99%
“…2 The most common genotypes of rotavirus detected around the world include the G types G1, G2, G3, G4, and G9, in association with the P types P [8], P [6], and P [4]. 3 However, many recent studies have described the detection of uncommon or untypable genotypes in developing countries. 4 Two live attenuated vaccines have been licensed and proven efficacious for protection against rotavirus infections, namely RotaTeq (Merck & Co., Whitehouse Station, NJ) and Rotarix (GlaxoSmithKline Biologicals, Rixensart, Belgium).…”
mentioning
confidence: 99%
“…Vomiting is a recognisable barrier to the effective use of ORT, as shown in other studies, mainly because caregivers are unaware of the need to continue ORT after the vomiting has subsided. 19 Although use of ORT does not reduce the incidence of diarrhoea, more than 90% of dehydration from diarrhoea can be prevented with its use, leading WHO to make it the mainstay of diarrhoea management. 20 In recognition of the fact that successful management of diarrhoea lies in the hands of well-informed caregivers rather than the health care system, the way forward is to support and inform caregivers about ORT so that they are more inclined to use it.…”
Section: 18mentioning
confidence: 99%